Bahl & Gaynor Inc. Has $5.20 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Bahl & Gaynor Inc. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,571 shares of the medical equipment provider’s stock after selling 237 shares during the quarter. Bahl & Gaynor Inc.’s holdings in Intuitive Surgical were worth $5,201,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ISRG. AlphaCore Capital LLC increased its holdings in shares of Intuitive Surgical by 40.6% in the second quarter. AlphaCore Capital LLC now owns 1,088 shares of the medical equipment provider’s stock valued at $591,000 after purchasing an additional 314 shares in the last quarter. Mufg Securities Americas Inc. boosted its position in Intuitive Surgical by 25.8% in the 2nd quarter. Mufg Securities Americas Inc. now owns 7,943 shares of the medical equipment provider’s stock valued at $4,316,000 after buying an additional 1,630 shares during the last quarter. Sfmg LLC bought a new position in Intuitive Surgical in the 2nd quarter valued at $228,000. AXQ Capital LP acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $1,280,000. Finally, Journey Strategic Wealth LLC raised its position in shares of Intuitive Surgical by 67.1% during the second quarter. Journey Strategic Wealth LLC now owns 2,821 shares of the medical equipment provider’s stock worth $1,533,000 after acquiring an additional 1,133 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Truist Financial set a $620.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. BTIG Research lifted their price target on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Leerink Partners boosted their price target on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Finally, The Goldman Sachs Group increased their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Trading Up 1.7%

Shares of Intuitive Surgical stock opened at $561.61 on Friday. The stock’s fifty day simple moving average is $492.09 and its 200 day simple moving average is $504.12. The company has a market capitalization of $201.32 billion, a PE ratio of 74.29, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. The company’s revenue was up 22.9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.84 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. This trade represents a 9.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares in the company, valued at approximately $3,310,850. The trade was a 37.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 116,164 shares of company stock worth $61,916,172 in the last three months. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.